Patients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
Q&A with Patricia Ganz on chemotherapy-related nerve damage.
by Sue Rochman
Risk of stroke and heart increases after a cancer diagnosis.
by Robin Meadows
New product expected to be less expensive.
by Christina Bennett
Quick response to symptoms improves quality of life and survival.
by Cameron Walker
Study finds low vaccination rates among teen survivors.
Researchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
The microbes living in your gut may explain how diet influences colorectal cancer risk.
by Lori Miller Kase
Gum disease is associated with increased cancer risk.
by Kendall K. Morgan
Cancer epidemiologist Cornelia Ulrich discusses research that explores how fat cells and cancer cells communicate.
by Marci A. Landsmann
Stock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
An updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
Researcher speculates that costly genetic testing may be limiting outreach to underserved communities.
AACR leaders Margaret Foti, PhD, MD (hc), Elizabeth M. Jaffee, MD, and Elaine R. Mardis, PhD, share their stories.
The FDA approves an antihormone agent to treat prostate cancer.
Women who work the night shift may have an increased risk of developing some cancers.
The Financial Toll of Cancer
donate to the AACR